Drug
Bacillus Calmette-guerin
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Availability Issue | 236 | 126.3 | 145.6 | signal |
| 2 | Product Dose Omission | 177 | 31.8 | 35.2 | signal |
| 3 | No Adverse Event | 378 | 25.3 | 32.0 | signal |
| 4 | Micturition Urgency | 19 | 19.9 | 20.1 | signal |
| 5 | Therapy Non-responder | 72 | 19.2 | 20.0 | signal |
| 6 | Bladder Disorder | 14 | 16.7 | 16.8 | signal |
| 7 | Incorrect Product Storage | 17 | 15.2 | 15.3 | signal |
| 8 | Tuberculosis | 16 | 14.8 | 14.9 | signal |
| 9 | Dysuria | 43 | 13.9 | 14.2 | signal |
| 10 | Cystitis | 37 | 13.8 | 14.0 | signal |
| 11 | Haematuria | 39 | 13.5 | 13.8 | signal |
| 12 | Circumstance Or Information Capable Of Leading To Medication Error | 36 | 12.7 | 13.0 | signal |
| 13 | Expired Product Administered | 30 | 10.7 | 10.9 | signal |
| 14 | Incontinence | 8 | 9.0 | 9.0 | signal |
| 15 | Blood Urine Present | 14 | 8.7 | 8.8 | signal |
| 16 | Exposure Via Skin Contact | 15 | 7.9 | 7.9 | signal |
| 17 | Nocturia | 8 | 7.8 | 7.9 | signal |
| 18 | Pollakiuria | 25 | 7.1 | 7.2 | signal |
| 19 | Treatment Failure | 49 | 7.1 | 7.3 | signal |
| 20 | Prostatic Specific Antigen Increased | 8 | 6.9 | 6.9 | signal |
| 21 | Incorrect Route Of Drug Administration | 19 | 6.2 | 6.3 | signal |
| 22 | Urinary Incontinence | 15 | 6.0 | 6.1 | signal |
| 23 | Injury Associated With Device | 10 | 5.9 | 5.9 | signal |
| 24 | Product Preparation Error | 10 | 5.7 | 5.8 | signal |
| 25 | Accidental Exposure To Product | 46 | 5.5 | 5.6 | signal |
| 26 | Bladder Cancer | 25 | 5.0 | 5.0 | signal |
| 27 | Drug Dose Omission | 66 | 4.7 | 4.8 | signal |
| 28 | Abscess | 6 | 4.5 | 4.5 | signal |
| 29 | Product Dose Omission Issue | 107 | 4.5 | 4.7 | signal |
| 30 | No Therapeutic Response | 4 | 3.8 | 3.8 | signal |
| 31 | Adverse Event | 29 | 3.7 | 3.8 | signal |
| 32 | Product Packaging Quantity Issue | 3 | 3.3 | 3.3 | no signal |
| 33 | Metastases To Lung | 3 | 3.1 | 3.1 | no signal |
| 34 | Drug Administration Error | 8 | 3.1 | 3.1 | signal |
| 35 | Inappropriate Schedule Of Drug Administration | 18 | 3.0 | 3.0 | signal |
| 36 | Incorrect Product Administration Duration | 5 | 2.9 | 2.9 | signal |
| 37 | Malignant Neoplasm Progression | 24 | 2.8 | 2.8 | signal |
| 38 | Erectile Dysfunction | 6 | 2.8 | 2.8 | signal |
| 39 | Underdose | 17 | 2.8 | 2.8 | signal |
| 40 | Product Physical Issue | 4 | 2.4 | 2.4 | no signal |
| 41 | Product Quality Issue | 27 | 2.4 | 2.4 | signal |
| 42 | Incorrect Dose Administered | 44 | 2.3 | 2.4 | signal |
| 43 | Product Storage Error | 16 | 2.2 | 2.2 | signal |
| 44 | Drug Exposure During Pregnancy | 4 | 1.4 | 1.4 | no signal |
| 45 | Device Leakage | 3 | 0.8 | 0.8 | no signal |